The next generation virus‐like particle platform for the treatment of peanut allergy

Background Allergy to peanut is one of the leading causes of anaphylactic reactions among food allergic patients. Immunization against peanut allergy with a safe and protective vaccine holds a promise to induce durable protection against anaphylaxis caused by exposure to peanut. A novel vaccine cand...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy (Copenhagen) Jg. 78; H. 7; S. 1980 - 1996
Hauptverfasser:	Sobczak, Jan M., Krenger, Pascal S., Storni, Federico, Mohsen, Mona O., Balke, Ina, Reseviča, Gunta, Heath, Matthew D., Carreno Velazquez, Thalia L., Kramer, Matthias F., Scott, Callum J. W., Skinner, Murray A., Zeltiņš, Andris, Kündig, Thomas M., Vogel, Monique, Bachmann, Martin F.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Denmark Blackwell Publishing Ltd 01.07.2023
Schlagworte:	Allergens Allergies Anaphylaxis Animal models Animals Antigens, Plant Ara h 2 antigen Arachis capsid cross immunity Cucumber mosaic virus Epitopes Food allergies Immunization Immunogenicity Immunoglobulin G Immunotherapy Mice novel therapy peanut allergy Peanut Hypersensitivity - prevention & control peanuts Prospective Studies T-lymphocytes vaccination vaccine Vaccines Viruses virus‐like particles peanut allergy virus-like particles vaccine novel therapy
ISSN:	0105-4538, 1398-9995, 1398-9995
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!